Spire Wealth Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
NIMC
AIM
GCM
MAM
Spire Wealth Management's CELL Position: Q4 2022 in Review
Spire Wealth Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 236 shares — an estimated $1K sold.
Spire Wealth Management first reported a position in CELL in Q4 2021 and held it in 4 quarters. The position peaked at $48K in Q4 2021. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.
- Spire Wealth Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Spire Wealth Management sold 236 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $1K.
- Spire Wealth Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 4 quarters.
- Spire Wealth Management's PhenomeX Inc. Common Stock position peaked at $48K in Q4 2021.
- 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.
Based on Spire Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.